While prediction markets remain hard to allocate to directly, their clearest near-term use case for hedge funds may be informational rather than transactional. Prediction-market prices can offer continuously updated, market-implied probabilities for events such as elections, rate decisions, litigation outcomes, regulatory approvals, economic releases and corporate catalysts.
Unlike traditional polling, sell-side commentary or periodic surveys, prices can move in real time as news develops. This could make them useful inputs for macro dashboards, scenario planning and portfolio-risk discussions. Client conversations suggest this monitoring use case is more realistic near term than direct trading, with prices serving as another sentiment indicator alongside options-implied probabilities, betting odds, surveys, news analytics and alternative data.
Even firms that never trade the contracts may still find value in the data. A portfolio manager may not want to buy or sell a political event contract, but the market-implied probability embedded in it could still inform discussions around positioning, hedging, risk limits or client communications.
Contract Design May Be the Core Risk
Acting on the signal remains harder than reading it, and the reason often sits in the fine print. For institutional users, the resolution criteria, settlement source, timing, appeal process, position limits and any ambiguity around the outcome can each materially affect the risk profile.
A contract asking whether a candidate wins an election, whether a government shutdown occurs, or whether a drug receives FDA approval may appear straightforward. But institutional investors will need to understand exactly how the platform defines the event, what source determines the result, when the contract settles, and what happens if the outcome is delayed, disputed or only partially aligned with the economic exposure the investor intended to hedge.
This is particularly relevant for more complex corporate, regulatory or clinical events. The more bespoke or nuanced the event, the greater the risk that the contract does not hedge the investor’s actual exposure. For hedge funds, that means prediction-market analysis extends past probability assessment to the legal, operational and compliance review of the contract itself.
Biotech Use Cases Remain More Theoretical Than Practical
Biotechnology is one area where prediction markets seem especially relevant. Biotech investing often centers on discrete catalysts such as clinical trial readouts, FDA decisions and patent disputes: exactly the kind of binary events these contracts are built around. In practice, there is limited evidence that biotech-focused hedge funds are using prediction markets to trade clinical or regulatory events as part of a formal investment process.
One practical limitation is that major platforms appear to offer trading on a relatively narrow set of more easily adjudicated FDA decisions, rather than the more complex clinical-trial events that many biotech investors focus on. While some managers may view pricing as a sentiment indicator and occasional mispricings may emerge, low trading volumes and wide spreads can limit the practical utility of these markets for institutional strategies.
A recent example illustrates the gap. In a case tied to a biotech approval, the implied probability in the market sat meaningfully below where many investors would have underwritten the outcome — on paper, a clear signal. But there was no efficient way to express the view: liquidity was extremely limited, and the same exposure could be replicated more cleanly through listed options on the underlying equity. Even so, the price did its real work as a signal: it flagged a gap between market consensus and fundamental conviction that a manager could act on through other instruments.
AI Agents Could Accelerate Monitoring, but Controls Matter
AI agents may make prediction-market data more usable inside investment workflows. In theory, agents could monitor relevant contracts, ingest news and alternative datasets, estimate fair probabilities, compare those probabilities with market-implied odds and flag potential discrepancies for analysts or traders. A practical workflow could:
- Identify relevant contracts and pull historical price and volume data.
- Incorporate polling, macro data, regulatory calendars, company-specific information or proprietary research.
- Estimate an internal probability and compare it with market-implied pricing.
- Adjust for liquidity, fees, transaction costs and position limits.
- Escalate potential opportunities for human review, monitoring new information and updating probabilities over time.
However, this also creates governance questions. Any agentic workflow connected to prediction markets would need controls around data permissions, explainability, model drift, audit trails, trading limits, liquidity, market impact and human supervision. For most hedge funds, the realistic first application is monitoring and alerting: agents that surface where market-implied odds diverge from internal estimates and leave the trading decision to a person.
Part of the Alternative-Data Stack
Prediction-market data may also become part of the broader alternative-data ecosystem. As AI models become more widely available, differentiated data, clean pipelines and clear data rights may become more important sources of edge. Prediction-market prices could be one input among many, alongside options markets, news analytics, web data, polling, consumer data, geolocation data or proprietary research — more useful when combined with internal research and other market signals than on their own.
The same issues apply here as for alternative data more broadly. Managers would need to understand licensing rights, permitted use, data provenance, retention policies and whether the data can be used for research, trading, redistribution or AI-model training. As AI tools spread, prediction-market data earns its place as one more probability signal, most valuable for how it combines with proprietary research and other differentiated inputs.
The Value Is in the Read
Across these use cases, the most dependable value today is in the pricing itself. A continuously updated, market-implied probability is something a manager can put to work immediately: a live read on how the market is pricing a given catalyst, refreshed as the news moves. The biotech case made the point well: even where the contract could not be traded, the price still told managers something useful about where consensus sat. This is where prediction markets are most useful to hedge funds right now, as a real-time probability signal that sharpens research and risk discussions.
That usefulness brings its own demands. Once these prices feed into a documented process, and once employees begin trading the contracts in personal accounts, managers face a practical governance question: how to monitor the activity and set the right controls around it. That is the focus of the final piece.
Next in the series — Part 3: Risk & Compliance. How managers are approaching oversight of prediction-market activity, including employee personal trading.
